Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)
Praxis Precision Medicines' quarterly Revenue came in at $7.5 million in Q4 2024, up 1349.13% year-on-year from $515000.0 in Q1 2024, and up 2371.19% quarter-over-quarter from $302000.0 in Q3 2024.
Praxis Precision Medicines has reported Revenue for 2 years, with the latest figure at $7.5 million in Q4 2024.
- For the quarter ending Q4 2024, Revenue rose 1349.13% year-over-year to $7.5 million; the trailing twelve-month figure through Sep 2025 stood at $7.5 million (up 364.98% YoY), and the FY2024 full-year result was $8.6 million, up 249.53% from the prior year.
- Revenue for Q4 2024 stood at $7.5 million, up from $302000.0 in the prior quarter.
- The five-year high for Revenue was $7.5 million in Q4 2024, with the low at $302000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.46 Mn |
| Sep 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 431,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Sep 30, 2023 | 468,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 683,000.00 |